Matthew Wolff, MD
NPI 1528029964 · Interventional Cardiology Physician · Madison, WI
Enrolled with Medicare as Practitioner - Interventional Cardiology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1528029964
- Entity type
- Individual
- Primary specialty
- Interventional Cardiology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 33845 (WI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
6,497 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Blood Test, Clotting Time85610 | 3,775 | $4 |
| Physician Review, Interpretation, and Patient Management of Home Inr Testing for Patient With Either Mechanical Heart Valve(s), Chronic Atrial Fibrillation, Or Venous Thromboembolism Who Meets Medicare Coverage Criteria; Testing Not Occurring More FrequentG0250 | 1,512 | $8 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 941 | $9 |
| Blood Count, Hemoglobin85018 | 99 | $2 |
| Platelet Count, Automated Test85049 | 80 | $4 |
| Exercise Or Drug-Induced Heart Stress Test With Electrocardiogram (ecg) With Review By Physician93018 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Warfarin Sodium | 3,524 | 731 |
| Apixabanbrand: Eliquis | 601 | 112 |
| Enoxaparin Sodium | 97 | 57 |
| Warfarin Sodiumbrand: Jantoven | 74 | 18 |
| Rivaroxabanbrand: Xarelto | 17 | — |
| Dabigatran Etexilate Mesylatebrand: Dabigatran Etexilate | 12 | — |
These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-28
- Last updated
- 2021-01-13
- Certified
- 2021-01-13
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.